Summary Mastectomy probably represents over-treatment for the majority of women with screen detected ductal carcinoma in situ (DCIS) and breast-conserving surgery is now widely advocated. In this study, biopsy cavity shavings were used to ensure Ductal carcinoma in situ (DCIS) has become clinically important only since the advent of routine high-quality mammography, and now accounts for 20-25% of screen-detected breast malignancies (Verbeek et al, 1984) . The majority of screen detected DCIS lesions, however, are asymptomatic and impalpable (Gump et al, 1987) .
Ductal carcinoma in situ (DCIS) has become clinically important only since the advent of routine high-quality mammography, and now accounts for 20-25% of screen-detected breast malignancies (Verbeek et al, 1984) . The majority of screen detected DCIS lesions, however, are asymptomatic and impalpable (Gump et al, 1987) .
Despite the increase in diagnosis, the optimal surgical treatment for DCIS remains controversial. Until recently, DCIS was not differentiated from invasive breast carcinoma and was treated by mastectomy (Price et al, 1989) . Since the widespread acceptance of breast-conserving surgery for early invasive breast cancer however, mastectomy is becoming more difficult to justify for localized screen-detected DCIS The main purpose of breast-conserving surgery for invasive or in situ disease is complete excision of the tumour (both macroscopically and microscopically) with a surrounding margin of normal tissue to prevent local recurrence, while maintaining a cosmetically acceptable breast. Unfortunately, there is no regular consensus regarding the definition of complete excision or of an adequate margin of excision. It is clear that the margin of clearance around an invasive tumour correlates with local control rates, with positive resection margins being associated with an increased risk of local recurrence (Veronesi et al, 1990) . However, the volume of excised tissue is inversely proportional to the cosmetic outcome (Wazer et al, 1992) .
Recurrence rates after local excision of DCIS vary widely among different studies and may reflect the type of surgery, adequacy of excision margins, DCIS pathology and patient selection criteria in each study. It is generally agreed that after local surgery up to 30% of women with DCIS will have recurrent lesions within 15 years, but, more importantly, up to 50% of patients will have invasive breast carcinoma on recurrence (Price et al, 1989) .
Inadequate excision of the primary lesion appears to be one of the most important causes of local failure after breast-conserving surgery (Silverstein et al, 1994) , and new prognostic index for DCIS has been proposed recently that includes resection margins as one of its predictive factors (Silverstein et al, 1996) . The Van Nuys prognostic index (VNPI) also quantifies two other predictors of local recurrence, namely DCIS size and pathological classification. A numerical system is used to predict patients more likely to recur after breast conserving surgery.
The histological evaluation of excision margins is now known to be a critical part of the assessment of any patient with DCIS being considered for breast-conserving treatment, and various techniques have been used to improve the accuracy, including inking of specimen margins, two-dimensional radiography, cavity shavings and tumour bed biopsies. Biopsy cavity shavings are routinely used in our unit after wide local excision of invasive carcinomas to reduce the incidence of re-excision in patients with the tumour extending close to the main specimen margin.
The aim of this study was to determine the effectiveness of using biopsy cavity shavings to ensure complete excision of screen-detected DCIS lesions.
PATIENTS AND METHODS
Screening mammography is performed at the Nightingale Breast Screening Centre, University Hospital of South Manchester. Patients with mammographic evidence of malignant microcalcification or a After the excision of the lesion, four quadrant cavity-wall shavings (range 2-5) were taken routinely. The excised specimens were orientated with ligaclips, before being submitted to twodimensional compression radiography, to ensure excision of the mammographic abnormality. If biopsy margins appeared close to the radiological lesion, further shavings were taken from the appropriate margin of the cavity.
In the histopathology laboratory, a standard protocol was followed: main specimens and cavity shavings were measured and then painted with India ink before sectioning, after which further radiographs were taken of all localization biopsies. Particular attention was paid to the margin of each biopsy, in particular in regions of either gross or radiological in situ disease. Biopsy specimens and their cavity shavings were blocked in their entirety.
Histopathological margin status of the main specimen was defined as follows: clear, DCIS > 1 mm from any inked margin of excision; involved, DCIS at any inked margin of excision; and close, DCIS < 1 mm from any inked margin of excision.
Irrespective of cavity shavings, patients with involved margins underwent formal re-excision and further cavity shavings were taken. Patients with clear or close margins were submitted to formal re-excision only if one or more cavity shaving contained DCIS. Again, further cavity shavings were taken at the time of reexcision.
After complete excision, 61 patients received adjuvant therapy, either tamoxifen (n = 41) or breast irradiation (n = 15) or a combination of the two (n = 5).
Post-operatively, women were examined clinically every 3 months for the first year, and underwent two view mammography on an annual basis. Women with mammographic suspicion of recurrent DCIS (malignant microcalcification) underwent a further needle localization biopsy to confirm the diagnosis. A diagnosis of recurrent DCIS after local excision invariably led to simple mastectomy.
Retrospectively, a modified VNPI (MVNPI) score was calculated from size score (1-3) + nuclear grade score (1-3) + margin status score (2-3), to give each patient's DCIS lesion a score ranging from 4 (best prognosis) to 9 (worst prognosis). In common with the VNPI (Silverstein et al, 1996) , a score of 1 was given for lesions < 15 mm, 2 for lesions 16-40 mm and 3 for lesions > 41 mm. Our pathological score included nuclear grade alone, with low nuclear grade lesions scoring 1, intermediate grade lesions 2 and high-grade lesions 3. We used a margin status score of 2 for clear (> 1 mm) margins and a score of 3 for close (< 1 mm) margins. Statistical analysis was performed using the x2 test with Yates' correction and the Mann-Whitney U-test.
RESULTS
During a 58-month period from January 1991 to November 1995, a series of 129 women with localized screen-detected DCIS were diagnosed and treated with breast-conserving surgery. Median age at diagnosis was 57 years (range 34-78 years).
By far the commonest mammographic abnormality was microcalcification (113 out of 129, 87.6%); a mammographic mass lesion was present in the remaining patients (16 out of 129, 12.4%). Clinically, 105 (81.4%) of the mammographic lesions were considered impalpable and 24 (18.6%) palpable.
Initial surgery consisted of open biopsy in 11 patients with clearly palpable lesions and a needle localization procedure in 118 patients. Thirteen patients with minimally palpable disease also underwent localization. Specimen radiography confirmed excision of the mammographic abnormality in each case. The median weight of the main specimen was 20.5 g (range 5-61 g). The median size (and ranges) of the main specimen was 50 mm (90-30 mm) x 40 mm (80-20 mm) x 22 mm (40-10 mm). Cavity shavings were measured in their maximum diameter only. Median sizes (and range) were, superior 25 mm (45-10 mm), medial 20 mm (50-8 nm), lateral 18 mm (45-9 mm), inferior 22 mm (35-10 mm) and deep 20 mm (38-10 mm).
Histopathology revealed pure comedo DCIS in 21 out of 129 (16.3%), pure non-comedo in 31 out of 129 (24.0%) and a mixture of comedo/non-comedo in 76 out of 129 (59.7%). Microinvasion (invasion < 1 mm) was seen in 16 (12.4%) cases. Of these, six (37.5%) were pure comedo, one (6.25%) non-comedo and nine (56.25%) mixed comedo/non-comedo DCIS. Microinvasive lesions were considered to be poorly differentiated in 15 out of 16 (93.7%) cases and intermediately differentiated in 1 out of 16 (6.3%). The median size of all DCIS lesions at initial biopsy was 12 mm (range 2-40 mm). One hundred and four women had close or clear margins with no involvement of shavings, whereas 25 had involved margins, nine (30%) of whom had positive cavity shavings.
Involvement (or close proximity of DCIS) of main specimen margins (n = 47; see Table 1 ) or cavity shavings (n = 9) after initial needle localization or open biopsy led to re-excision, with further cavity shavings being taken in each case. Margin status after initial and re-excisional biopsy is shown in Table 1 . After re-excision, cavity shavings were reported as histologically clear of DCIS in all (Figure 1 , P < 0.001, Mann-Whitney U-test).
DISCUSSION
Breast-conserving surgery is now widely advocated in the management of screen-detected DCIS. The main problem with breast conservation is local recurrence. After planned local excision of DCIS, without post-operative radiotherapy, various recurrence rates have been reported: 8% after a median follow up of 18 months (Silverstein et al, 1992) , 15% at 4 years (Lagios et al, 1982) , 23% at 39 months (Fisher et al, 1986 ), 55% at 7 years (Price et al, 1989 ), 63% at 9 years (Price et al, 1990) . The number of local recurrences increases with time; Fisher's recurrence rate of 23% at 39 months increased to 43% at 83 months (Fisher et al, 1991) .
There is, as yet, no evidence to indicate that initial failure in local control adversely affects survival, but local recurrence is a great source of anxiety and psychological morbidity to the patient and her family (Jenkins et al, 1991) , in particular as the majority of patients with recurrent DCIS are treated by mastectomy in the United Kingdom.
For invasive breast cancers, cavity shavings and tumour bed biopsies have been found to be useful in identifying a group of patients who are potentially at a higher risk of local relapse after conservative surgery and may benefit from re-excision (Macmillan et al, 1994) . In our own unit, involvement of biopsy specimen resection margins or cavity shavings have been shown to correlate with residual invasive or in situ disease within the conserved breast (Walls et al, 1995) . In this present study, cavity shavings were used in an attempt to identify DCIS patients with close or involved margins as inadequate excision of the primary lesion is probably the most important cause of local failure after breastconserving surgery for DCIS (Silverstein et al, 1996) . Unfortunately, there is, as yet, no established definition of what constitutes a clear margin of excision. The NSABP B-17 trial (Fisher et al, 1995) was the first major randomized prospective trial of treatment for localized DCIS. In this study, margins were regarded as free when the tumour was not transected. Pathological assessments indicating lesions to be 'close' or 'too close' (< 1 mm) to the resection margin were not considered to represent margin involvement. Their results have shown local recurrence rates of 13.9% after a mean follow-up of only 24 months. Is this relatively high incidence of local recurrence related to inadequate excision? Studies on mastectomy specimens after a biopsy showing DCIS have shown residual DCIS at the original biopsy site in an average of 44% of cases (range 16-78%), (Fentiman et al, 1986; Fisher et al, 1986; Gump et al, 1987) . Histologically C) Cancer Research Campaign 1998 negative margins do not guarantee that residual DCIS has not been left behind. In a study by Silverstein, 181 patients were treated by wide local excision. Clear margins were defined as no DCIS within 1 mm of any margin. All patients subsequently underwent mastectomy or re-excision of the biopsy site. Not surprisingly, 76% of patients with initially involved margins had residual DCIS, but so did 43% of patients initially considered to have clear margins (Silverstein et al, 1994) . These data indicate that many of the recurrences in the NSABP Protocol B-17 trial were in fact examples of residual disease and not true recurrences. This hypothesis is supported by patterns of failure studies that have shown that during the first 10 years after breast-conserving surgery, 70-80% of recurrences occur within the same quadrant as the original surgery (Kurtz et al, 1990) . Furthermore, the relapse rate of 13.9% in the NSABP B-17 trial was reduced to 5% with the addition of post-operative radiotherapy (Fisher et al, 1995) .
In our study, despite cavity shavings being clear in all cases, the incidence of ipsilateral local relapse was 9.3% after a median follow-up of only 14 months. This incidence of relapse is clearly unsatisfactory. All recurrences occurred at or near the site of the original biopsy and had similar or identical histological features. Seven out of the twelve recurrences were detected by the first annual mammogram. As our definitions of involved, close and clear resection margins were similar to those described in the earlier studies, there seems little doubt that our relapses represent residual DCIS rather than true recurrence, in the majority of cases.
The Van Nuys prognostic index (VNPI) combines three significant predictors of local recurrence, namely margin width, tumour size and pathological classification to predict local recurrence after breast conserving surgery (Silverstein et al, 1996) . DCIS patients with VNPI scores of 3 or 4 had a low risk of local relapse, whereas patients with scores of 8 or 9 had a very high risk of local relapse. Patients with a score of 5, 6 or 7 had an intermediate risk. The calculation of our modified score (MNVPI) differed from VNPI in two ways. First, nuclear grade was the only pathological criterion included, the presence or absence of comedo-type necrosis was not assessed. Second, only two groups were included in the margin status score. Tumours were considered completely excised if margins were greater than 1 mm, but the exact size of these clear margins could not be accurately assessed retrospectively. Despite these differences, our MVNPI correlated well with the incidence of local recurrence, but this may merely reflect the fact that MVNPI is also strongly correlated with close margin status. We agree with the Van Nuys group that margin status, size and histological features are the most reliable predictors of local relapse after breast-conserving surgery, but for the majority of screen detected DCIS cases we feel that margin status remains the most important single factor. Tumours greater than 40 mm in size are probably not suitable for breast conservation, irrespective of other factors.
Why have cavity shavings proved to be an inaccurate method of assessing complete excision of DCIS lesions in our study? The majority of biopsies were diagnostic and United Kingdom guidelines exist to minimize the volume of breast tissue removed in benign cases (Quality Assurance Guidelines for Surgeons in Breast Cancer Screening). Initial biopsy specimens were therefore small, the median weight of our recorded initial biopsies was only 20.5 g. To preserve cosmesis, cavity shavings were smaller than the main specimen in the majority of cases. In multifocal lesions at least, the surgical margin and or cavity shavings may lie between the tumour foci, giving the false impression of a free margin.
Increasing experience with stereotactic FNAC will allow a preoperative diagnosis of malignancy to be made, and enable us to perform a therapeutic biopsy with a wider margin of excision. A recent study has explored the three-dimensional structure of the various types of DCIS using a stereoscopic technique (Faverly et al, 1994) . This study showed that poorly differentiated DCIS nearly always grows continuously, although well-differentiated DCIS usually has a multifocal distribution. In cases of true multifocal disease, the gaps between foci are short (< 1 cm in 83% of cases). The authors of this study suggest that at the time of resection, a 1 cm rim of normal breast tissue should be excised around the primary lesion. With this approach, complete excision should be possible for approximately 90% of DCIS cases, irrespective of histological subtype. Complete local excision is an essential requirement before entry into several on-going prospective trials of adjuvant therapy for DCIS, but no guidance as to the minimum margin of excision is given. Evidence from both this and previous studies suggest that this might lead to inadequate local excision and high local recurrence rates in some cases. We feel that to accurately assess the effect of adjuvant treatments such as tamoxifen or radiotherapy in preventing true DCIS relapse and progression, DCIS lesions must be completely excised. In this study, recurrence occurred in five patients receiving adjuvant tamoxifen therapy, however in the presence of almost certain residual disease, the efficacy of tamoxifen as a chemopreventative agent cannot be assessed.
Most authors now agree that recurrences after local excision of DCIS most likely reflect residual disease, and several studies clearly suggest that 1 mm is an inadequate margin of excision (Lagios et al, 1982; Holland et al, 1990; Silverstein et al, 1994; . A tissue margin of 1-2 cm from the edge of the mammographically assessed lesion seems necessary to ensure that histological assessment of the margin is accurate. In our hands, biopsy cavity shavings have proved to be inadequate in assessing complete excision of screen-detected DCIS lesions using a clear margin of excision of 1 mm. With the aid of stereotactic FNAC, our clinical practice has now changed. We aim to perform a therapeutic biopsy at the initial procedure whenever possible, and proceed to elective wider excision if DCIS is close to the main specimen margin. We try to ensure a clear histological margin of 5-10 mm in each case; with such a margin, cavity shavings become irrelevant.
